Blog

Unlike traditional commercial bank stocks, which were hit hard by the coronavirus pandemic, investment banks have fared much better. While mergers and acquisitions activity has lagged, investment

Up more than 45% in the past three months, HEXO (NYSE: HEXO) and Trulieve Cannabis (CNSX: TRUL)(OTC: TCNNF) have investors talking. In a short period of time, both companies have generated

Stocks are one of the best wealth-building tools available, and with the new year approaching, there's no better time to put some money to work.

Whether you are new to stocks or a veteran looking

Investing in dividend growth stocks can be a great way to see your recurring income increase over the years. But some dividend stocks only increase their payouts by 1% or 2% each year. And while

When you're right in the middle of a bull market, timing the market can seem like a good move. Your investments are moving up and your account balances are increasing -- which is exciting! 

But it's

If you had bought $10,000 in BioNTech (NASDAQ: BNTX) on the date of its IPO in Oct. 2019, your investment would be worth well over $68,820 as of Dec. 16. There is one key reason for the spectacular

Warren Buffett, the chairman and CEO of Berkshire Hathaway, has held Moody's (NYSE: MCO) in his portfolio for 20 years, as of October. The credit rating and data analytics company is his

To determine how popular a given stock is with investors, look at its average daily trading volume. Stocks with high trading volumes tend to be at the center of investors' attention.

Based on this

When it comes to making money, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett is at the head of the class. Between 1965 and 2019, Buffett led Berkshire Hathaway's stock to an

Many people assume that once they retire, they'll manage to live on income received from Social Security. But will that really be the case?

If you're convinced you can manage on Social Security

Some investors think the ship has already sailed when it comes to investing in Moderna (NASDAQ: MRNA). With a market cap of well over $50 billion, Moderna's opportunities for its COVID-19 vaccine

2020 will go down in history as the year of the COVID-19 pandemic. For investors, 2020 has also been the year of growth stocks. Investor favorites like Tesla, Zoom, The Trade Desk, Square, Fastly

Winter is coming, but the stock market is heating up. Despite one of the wildest years in history, the benchmark S&P 500 looks as if it'll end the year higher by double digits. That's pretty

What better way to end a most forgettable year than to purchase some stocks that will pay you dividends? In fact, Broadcom (NASDAQ: AVGO), Orange SA (NYSE: ORAN), and Applied Materials (NASDAQ:

Image source: The Motley Fool.

Qutoutiao Inc (NASDAQ: QTT)Q3 2020 Earnings CallDec 17, 2020, 8:00 p.m. ET

Operator

Continue reading

Source Fool.com

Streaming-TV platform company Roku (NASDAQ: ROKU) has finally reached a deal to bring HBO Max to its platform. AT&T (NYSE: T) launched HBO Max back in May and had reached a deal with Amazon.com to

Small biotech companies have notoriously volatile stocks. Positive results from early lab work or clinical trials can fuel investors' imaginations. It doesn't hurt that every once in a while a

Shares of Moderna (NASDAQ: MRNA) fell 6.9% on Wednesday, following a cautionary note from analysts at a respected investment bank.

Morgan Stanley analyst Matthew Harrison cut his rating on Moderna's

Shares of Triterras (NASDAQ: TRIT) skyrocketed today after an analyst initiated coverage of the company's stock with an outperform rating.

The tech stock was up by as much as 20.8% today, but it

Image source: Getty Images.

While it doesn't influence our opinions of products, we may receive compensation from partners whose offers appear here. We're on your side, always. See our full

Image source: Getty Images.

While it doesn't influence our opinions of products, we may receive compensation from partners whose offers appear here. We're on your side, always. See our full

The stock market finished Wednesday on a mixed note, as we've seen increasingly over the past couple of weeks. Talk of economic stimulus is starting to get louder, and that helped bolster broader

We often refer to coronavirus vaccine makers as "rivals." But there actually is room for many of these players, considering global need for a vaccine. Several of these companies and their vaccines

Shares of medical and surgical equipment manufacturer Owens & Minor (NYSE: OMI) closed 7.1% lower Wednesday after the company filed a Form S-8 registration statement with the Securities and Exchange

The coronavirus vaccine race isn't over. And that means there are plenty of investment opportunities -- whether you're a cautious investor or you're comfortable with high risk. In this Motley Fool